Ophthalmic lasers are used to treat a wide variety of diseases and conditions, but these devices are primarily used to treat retinal disease, glaucoma, and a common complication to cataract surgery. Use of lasers to treat these ophthalmic conditions has been common practice for more than 20 years, and the last major technical progress was made in the mid 1990s with the introduction of diode lasers to replace the older gas lasers. Also, the introduction of the SLT laser, a treatment breakthrough employing a lower power, shorter pulse version of existing technology, has helped to grow the category.
Global demand for ophthalmic lasers (exclusive of excimer and femtosecond lasers) along with maintenance, accessories, and endoprobes is expected to grow at a compounded rate of 10.3 percent from 2008 to 2013. Demand will be based on expansion in access to advanced medical treatment (retinal surgery and glaucoma treatment) in the developing world and rapid growth in the segment of the global population over age 65 that has a high prevalence of retinal disease.
Our Comprehensive Report on the Global Ophthalmic Laser Market (exclusive of excimer and femtosecond lasers) is the leading industry source for accurate and relevant information on all aspects of the market. A table of contents is listed below.
The data included in our reports is based on surveys of ophthalmic surgeons, extensive reviews and analysis of clinical data, interviews with company executives and analysis of financial data.
The 2008 Comprehensive Report on the Global Ophthalmic Laser Market (exclusive of femtosecond and excimer) was published in October 2008 and is printed in color and spiral bound for ease of reading. The price of the report is $3,000; additional copies are available for use within your company for $300 each.